about
Efficacy of antioxidant in idiopathic pulmonary fibrosis: A systematic review and meta-analysisA review of current and novel therapies for idiopathic pulmonary fibrosisEfficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Ten-Year Survival in Patients with Idiopathic Pulmonary Fibrosis After Lung Transplantation.Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition.Pirfenidone suppresses TGF‑β1‑induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic update in idiopathic pulmonary fibrosis.
@en
Therapeutic update in idiopathic pulmonary fibrosis.
@nl
type
label
Therapeutic update in idiopathic pulmonary fibrosis.
@en
Therapeutic update in idiopathic pulmonary fibrosis.
@nl
prefLabel
Therapeutic update in idiopathic pulmonary fibrosis.
@en
Therapeutic update in idiopathic pulmonary fibrosis.
@nl
P2093
P2860
P1476
Therapeutic update in idiopathic pulmonary fibrosis.
@en
P2093
Andrew L Chan
Rokhsara Rafii
Samuel Louie
Timothy E Albertson
P2860
P2888
P356
10.1007/S12016-010-8244-9
P577
2013-02-01T00:00:00Z